Cargando…
TNF-α Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in an Experimental Model of Atherosclerosis
Atherosclerosis (AS) is an inflammatory disease involving multiple factors in its initiation and development. In recent years, the potential application of mesenchymal stem cells (MSCs) for treating AS has been investigated. This study examined the effect of TNF-α preconditioning on MSCs’ therapeuti...
Autores principales: | Sekenova, Aliya, Li, Yelena, Issabekova, Assel, Saparov, Arman, Ogay, Vyacheslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526914/ https://www.ncbi.nlm.nih.gov/pubmed/37759485 http://dx.doi.org/10.3390/cells12182262 |
Ejemplares similares
-
Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis
por: Sarsenova, Madina, et al.
Publicado: (2021) -
Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response
por: Saparov, Arman, et al.
Publicado: (2016) -
Regeneration of Osteochondral Defects by Combined Delivery of Synovium-Derived Mesenchymal Stem Cells, TGF-β1 and BMP-4 in Heparin-Conjugated Fibrin Hydrogel
por: Sarsenova, Madina, et al.
Publicado: (2022) -
Deprivation of human natural killer cells and antitumor immune response
por: Ogay, Vyacheslav, et al.
Publicado: (2014) -
Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
por: Sarsenova, Madina, et al.
Publicado: (2022)